Call Options

11 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.78 - $17.4 $932,940 - $1.27 Million
73,000 Added 104.43%
142,900 $2.32 Million
Q1 2024

May 15, 2024

BUY
$10.67 - $14.43 $485,485 - $656,565
45,500 Added 186.48%
69,900 $986,000
Q4 2023

Feb 14, 2024

BUY
$8.12 - $10.63 $112,867 - $147,757
13,900 Added 132.38%
24,400 $254,000
Q3 2023

Nov 14, 2023

BUY
$7.48 - $10.7 $32,912 - $47,080
4,400 Added 72.13%
10,500 $107,000
Q2 2023

Aug 14, 2023

BUY
$7.2 - $9.47 $43,920 - $57,767
6,100 New
6,100 $45,000
Q3 2022

Nov 14, 2022

BUY
$6.86 - $11.95 $300,468 - $523,409
43,800 New
43,800 $353,000
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $1.47 Million - $2.96 Million
-219,800 Closed
0 $0
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $1.13 Million - $1.86 Million
-173,600 Reduced 44.13%
219,800 $2.15 Million
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $2.18 Million - $3.39 Million
353,200 Added 878.61%
393,400 $2.71 Million
Q2 2019

Aug 14, 2019

SELL
$8.12 - $15.72 $189,195 - $366,276
-23,300 Reduced 36.69%
40,200 $371,000
Q1 2019

May 15, 2019

BUY
$15.58 - $20.01 $989,330 - $1.27 Million
63,500 New
63,500 $996,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Walleye Capital LLC Portfolio

Follow Walleye Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Capital LLC with notifications on news.